Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia
Criteria for defining complete remission re-evaluated
April 19th, 2005
The criteria for defining complete remission (CR) in acute myeloid leukemia (AML) have been re-evaluated. In AML patients, CR "is the primary endpoint for the evaluation of induction treatment and treatment strategies," hematologists in the Netherlands explained. "However, the choice and application of the criteria for a hematological CR can often become a subject of debate because regeneration of >5% blasts may be present at the time of response evaluation; platelet and neutrophil recovery may be incomplete and marrow cellularity can vary," noted G.E. de Greef and colleagues at the Erasmus Medical Center in Rotterdam. In a...
Source: Cancer Weekly (2005-04-19)
|
